Filter
Reset all

Subjects

Content Types

Countries

AID systems

API

Certificates

Data access

Data access restrictions

Database access

Database licenses

Data licenses

Data upload

Data upload restrictions

Enhanced publication

Institution responsibility type

Institution type

Keywords

Metadata standards

PID systems

Provider types

Quality management

Repository languages

Software

Syndications

Repository types

Versioning

  • * at the end of a keyword allows wildcard searches
  • " quotes can be used for searching phrases
  • + represents an AND search (default)
  • | represents an OR search
  • - represents a NOT operation
  • ( and ) implies priority
  • ~N after a word specifies the desired edit distance (fuzziness)
  • ~N after a phrase specifies the desired slop amount
  • 1 (current)
Found 12 result(s)
DDBJ; DNA Data Bank of Japan is the sole nucleotide sequence data bank in Asia, which is officially certified to collect nucleotide sequences from researchers and to issue the internationally recognized accession number to data submitters.Since we exchange the collected data with EMBL-Bank/EBI; European Bioinformatics Institute and GenBank/NCBI; National Center for Biotechnology Information on a daily basis, the three data banks share virtually the same data at any given time. The virtually unified database is called "INSD; International Nucleotide Sequence Database DDBJ collects sequence data mainly from Japanese researchers, but of course accepts data and issue the accession number to researchers in any other countries.
The main goal of the CLUES-project is to provide constrained simulations of the local universe designed to be used as a numerical laboratory of the current paradigm. The simulations will be used for unprecedented analysis of the complex dark matter and gasdynamical processes which govern the formation of galaxies. The predictions of these experiments can be easily compared with the detailed observations of our galactic neighborhood. Some of the CLUES data is now publicly available via the CosmoSim database (https://www.cosmosim.org/). This includes AHF halo catalogues from the Box 64, WMAP3 resimulations of the Local Group with 40963 particle resolution.
The CCHDO provides access to standard, well-described datasets from reference-quality repeat hydrography expeditions. It curates high quality full water column Conductivity-Temperature-Depth (CTD), hydrographic, carbon and tracer data from over 2,500 cruises from ~30 countries. It is the official data center for CTD and water sample profile data from the Global Ocean Ship-Based Hydrographic Investigations Program (GO-SHIP), as well as for WOCE, US Hydro, and other high quality repeat hydrography lines (e.g. SOCCOM, HOT, BATS, WOCE, CARINA.)
Country
The Animal Sound Archive at the Museum für Naturkunde in Berlin is one of the oldest and largest collections of animal sounds. Presently, the collection consists of about 120,000 bioacoustical recordings comprising almost all groups of animals: 1.800 bird species 580 mammalian species more then150 species of invertebrates; some fishes, amphibians and reptiles
The Phonogrammarchiv is a multi-disciplinary research sound and video archive, covering holdings from all continents. Since its foundation in 1899 the Phonogrammarchiv has been building up its holdings by cooperating with Austrian scholars and archiving their collected material, or by fieldwork conducted by staff members on special topics exploring new fields of methods and contents. The main tasks comprise the production, annotation, cataloguing and long-term preservation of audio-visual field recordings, making the cultural heritage available for future generations and enabling the dissemination of the recordings as well as technical developments in the field of AV recording and storage. Thus the Phonogrammarchiv adds to infrastructural performance valuable to both the scholarly community and the public at large.
The eyeGENE® Research Resource is open for approved research studies. Application details here Researchers and clinicians are actively developing gene-based therapies to treat ophthalmic genetic diseases that were once considered untreatable.
Here you will find authoritative taxonomic information on plants, animals, fungi, and microbes of North America and the world.
The Antimicrobial Peptide Database (APD) was originally created by a graduate student, Zhe Wang, as his master's thesis in the laboratory of Dr. Guangshun Wang. The project was initiated in 2002 and the first version of the database was open to the public in August 2003. It contained 525 peptide entries, which can be searched in multiple ways, including APD ID, peptide name, amino acid sequence, original location, PDB ID, structure, methods for structural determination, peptide length, charge, hydrophobic content, antibacterial, antifungal, antiviral, anticancer, and hemolytic activity. Some results of this bioinformatics tool were reported in the 2004 database paper. The peptide data stored in the APD were gleaned from the literature (PubMed, PDB, Google, and Swiss-Prot) manually in over a decade.
Country
SISMER (Scientific Information Systems for the Sea) is Ifremer's service in charge of managing numerous marine databases and information systems which Ifremer is responsible for implementing. The information systems managed by SISMER range from CATDS (SMOS satellite data) to geoscience data (bathymetry, seismics, geological samples), not forgetting water column data (physics and chemistry, data for operational oceanography – Coriolis - Copernicus CMEMS), fisheries data (Harmonie), coastal environment data (Quadrige 2) and deep-sea environment data (Archimède). SISMER therefore plays a pivotal role in marine database management both for Ifremer and for many national, European and international projects.
Content type(s)
The global scientific community, international partners, the private sector, civil society, and other relevant stakeholders establish a voluntary platform to link clinical trials registers in order to ensure a single point of access and the unambiguous identification of trials with a view to enhancing access to information by patients, families, patient groups and others.